Otsuka Holdings
4578.T
#632
Rank
โ‚น2.668 T
Marketcap
โ‚น4,954
Share price
-0.72%
Change (1 day)
63.91%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2024 (TTM): โ‚น81.50 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚น14.47 Billion. In 2023 the company made an earning of โ‚น88.68 Billion a decrease over its 2022 earnings that were of โ‚น112.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น81.50 B-8.1%
2023 โ‚น88.68 B-20.82%
2022 โ‚น112.01 B-13.04%
2021 โ‚น128.81 B-19.69%
2020 โ‚น160.40 B13.78%
2019 โ‚น140.98 B52.13%
2018 โ‚น92.67 B11.32%
2017 โ‚น83.25 B-36.26%
2016 โ‚น130.61 B31.64%
2015 โ‚น99.21 B
2013 โ‚น206.46 B33.73%
2012 โ‚น154.38 B-4.78%
2011 โ‚น162.13 B46.23%
2010 โ‚น110.87 B